OSBONE Platform

About Curasan

Curasan is a commercial-stage biomaterials company with a legacy dating back to 1988, focused on bone grafting and tissue regeneration. It markets a portfolio of dental and orthopedic products, primarily based on its proprietary β-tricalcium phosphate technology, which are sold in approximately 50 countries. The company is headquartered in Frankfurt, Germany, with a U.S. subsidiary, and is led by a management team with deep experience in medtech turnarounds and commercialization. Its strategic direction includes expanding its global commercial footprint and advancing a growth factor research spin-off, novaxomx.

Therapeutic Areas